<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Self-monitoring of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (SMBG) in type 2 diabetic patients was compared across 14 countries </plain></SENT>
<SENT sid="1" pm="."><plain>There was an unexpectedly high SMBG-use in non-insulin-treated patients </plain></SENT>
<SENT sid="2" pm="."><plain>Reimbursement polices differed by country, region, insurance status, and patient income </plain></SENT>
<SENT sid="3" pm="."><plain>More rigorous and systematic data collection is needed to ensure evidence-based SMBG-use </plain></SENT>
</text></document>